How AI Search Is Recommending Medical Billing Services: Monthly Trends

Executive Summary

The July-to-August 2026 period brought measurable movement to the Medical Billing Services category, with two brands posting significant declines in how often AI systems place them in valid recommendation shortlists. athenahealth remains the category leader, though its own coverage slipped modestly from 50.3% in July to 47.6% in August, a change within normal month-to-month variation. The leader's position is stable, but the gap between athenahealth and the second-place brand widened this month rather than narrowing, as the next tier lost more ground than the leader did.

The most material movement came from DrChrono, whose valid recommendation coverage dropped 8.0 points from 28.9% in July to 20.9% in August, a significant decline and the largest single-month move in the category. This shift marks the sharpest downward change in the measured series and pulls DrChrono from a solid mid-tier position into a tighter cluster with eClinicalWorks and CureMD. DrChrono's raw mention presence also fell, from 39.9% to 36.2%, though that change was smaller in scale than the coverage decline.

AdvancedMD was the second significant decliner, with valid recommendation coverage falling 7.3 points from 40.3% in July to 33.0% in August. This movement pulled AdvancedMD from a clear upper-tier position into closer range of Tebra (Kareo), which also declined 4.9 points to 36.4% but remained within the band of normal month-to-month variation. No brand posted a significant rise this month; 9 of the 10 tracked brands recorded a decline in valid recommendation coverage, with only Medusind moving upward, and by a very small margin on a very small base.

The broader context: qualified observations spanned all six canonical AI surface families in both July and August, and all ten tracked brands recorded qualified appearances in both months. This month's decline in brand-level coverage coincides with a drop in the overall recommendation-shaped answer share, from 39.8% in July to 33.2% in August, though the benchmark cannot establish why that shift occurred.

Each monthly run begins with 800 prompt-surface observations (419 unique questions in July, 480 in August) across the benchmark's defined AI/search surface universe. Of those, 800 mentioned a tracked brand or competitor in both months; 747 were relevant and 53 were irrelevant in July, versus 764 relevant and 36 irrelevant in August. The public metrics use the 571 qualified observations in July and 588 in August that survive both qualification stages. Both months achieved qualified coverage across all six canonical AI surface families.

Key Findings

Benchmark Context

The report separates the raw collection universe from the qualified analysis set. Brand-level recommendation percentages are calculated within the qualified benchmark set.

With the collection and qualification stages established, the benchmark's headline metrics for the category are summarized below.

Benchmark-Level Metrics

Recommendation-shaped answers fell from 227 in July to 195 in August, even as the qualified observation count rose. The mix of response types also shifted: comparison analysis answers rose from 40 to 68, while recommendation shortlists fell from 213 to 185. This indicates the composition of AI responses in this category changed between the two months, though the benchmark cannot establish why AI systems produced more comparison-style answers and fewer shortlist-style answers this month.

AI Recommendation Trend

The category's leadership is stable but the middle of the table is in motion. athenahealth retains first place, but the significant declines from DrChrono and AdvancedMD mean fewer brands are earning a place in valid shortlists this month. The gap between the leader and the second-place brand widened, while the bottom of the table remained quiet.

Valid Recommendation Coverage by Brand

Two brands, DrChrono and AdvancedMD, moved beyond normal month-to-month variation, while the rest of the field declined within their expected bands. The net effect is a visible reordering in the middle of the table, with DrChrono and AdvancedMD losing ground they held in July.

What Changed This Month

DrChrono: Significant Coverage Decline

DrChrono's valid recommendation coverage fell 8.0 points from 28.9% in July to 20.9% in August, a significant decline and the largest single-month movement in the category. This move pulled the brand from a mid-tier position above eClinicalWorks into a tight cluster where it now sits just below eClinicalWorks's 21.8%.

The brand's raw presence also slipped, with mention presence falling from 39.9% to 36.2%, a shift smaller in scale than the coverage decline. Top-three recommendation rate declined from 6.8% to 6.1%, and rank-one rate dipped from 0.7% to 0.5%, both within normal variation.

The distinction to notice: DrChrono's coverage declined more than its presence, indicating that the drop in valid recommendations was not solely a byproduct of appearing less often in AI answers. The valid recommendation count dropped from 165 in July to 123 in August.

Highest-priority diagnostic: Which prompts previously produced a DrChrono recommendation and now surface a different brand, and which competitor is capturing those shortlist slots?

AdvancedMD: Significant Coverage Decline

AdvancedMD's valid recommendation coverage fell 7.3 points from 40.3% in July to 33.0% in August, a significant decline. This moves AdvancedMD from a clear upper-tier position into a tighter race with Tebra (Kareo), which now leads by 3.4 points.

Notably, AdvancedMD's raw mention presence rose slightly from 53.2% to 54.1%, and its rank-one rate rose from 2.3% to 3.2%. The brand is still appearing in AI answers at similar rates, but the valid recommendation count fell from 230 to 194.

The distinction to notice: AdvancedMD's presence rate rose slightly while its valid recommendation coverage fell, reflecting a difference between how often the brand appears in AI answers and how often it appears within a qualifying recommendation shortlist. Top-three rate declined from 23.3% to 21.1%, within normal variation.

Highest-priority diagnostic: In which prompt contexts did AdvancedMD appear without earning shortlist placement, and what attributes are AI systems citing for competing brands instead?

Tebra (Kareo): Notable Decline, Within Normal Variation

Tebra (Kareo)'s coverage fell 4.9 points from 41.3% in July to 36.4% in August, remaining within the band treated as normal month-to-month variation for this brand. The brand retains second place, but its rank-one rate dropped from 12.3% to 8.5%.

Raw mention presence held steady at 59.0% versus 58.5%, and the valid recommendation count fell from 236 to 214. The brand remains a frequent presence in AI answers but is being placed at the top of the shortlist less often.

The distinction to notice: Tebra (Kareo) is holding its breadth of presence while its rank-one placements declined more visibly than its overall coverage. That rank-one movement is the sharpest signal within this brand's data this month.

Highest-priority diagnostic: Which surface families and prompt types drove the decline in top recommendation placements, and which evidence sources now anchor competing brands at rank one?

Greenway Health: Presence Growth Without Coverage

Greenway Health's raw mention presence rose from 3.3% in July to 5.9% in August, while valid recommendation coverage remained low, dipping from 1.8% to 1.5%. The valid recommendation count is small, falling from 10 to 9 observations.

Rank-one rate fell from 0.2% to 0.0%.

The distinction to notice: the brand's presence rose while its valid recommendation coverage stayed roughly flat, meaning the increase in mentions did not correspond to a similar increase in valid recommendation coverage. Small counts mean this pattern warrants monitoring rather than a firm conclusion.

Highest-priority diagnostic: What is driving the increase in mentions, and in which contexts is the brand being named without being recommended?

Medusind: Small-Count Uptick

Medusind's valid recommendation coverage rose from 0.2% in July to 0.3% in August, a movement of 0.1 points, on valid recommendation counts of 1 in July and 2 in August.

Raw mention presence also rose from 0.7% to 0.9%, with presence counts of 4 in July and 5 in August.

The distinction to notice: these are very small absolute counts, and any movement here is directional only. Medusind remains at the bottom of the coverage table by a wide margin.

Highest-priority diagnostic: Which prompts produced the two valid recommendations, and what evidence sources are surfacing the brand at all?

Buyer-Intent Interpretation

In both July and August, all qualified observations in this vertical fell into the brand recommendation cluster. The benchmark found no qualified observations in the pricing and value or multi-brand comparison clusters. The public benchmark can measure which brands AI systems recommend, but it cannot yet answer commercial questions about price positioning, value perception, or direct head-to-head comparisons.

The response-type distribution does show that comparison analysis answers rose from 40 in July to 68 in August, and pricing analysis answers held roughly steady at 12 and then 11. These responses exist in the raw collection, but they did not qualify as valid recommendation observations. The commercial questions of price and comparison are therefore visible in AI answer behavior but not yet measurable at the benchmark level.

Brand Opportunity Summary

The benchmark identifies where attention is warranted; a company-level analysis is needed to explain why.

Evidence Behind the Benchmark

The aggregate metrics are built from prompt-level observations (query, surface, recommendation outcome, rank, sentiment, and citations where exposed). Company-level analysis can go deeper into prompt, competitor, surface, and evidence patterns. Source presence is not automatically treated as proof of causation.

About This Benchmark

This report is part of the LLM Authority Index AI Market Discovery research program.

• AI Industry Market Discovery Methodology
• AI Industry Market Discovery Metrics
• AI Industry Market Discovery Standards

Report-Specific Interpretation Notes

• Movement between months identifies changes worth investigating; it does not by itself establish the cause of those changes.
• Small-count brands (Greenway Health, Medusind) carry higher uncertainty; their movements are directional signals, not conclusive trends.
• The qualified benchmark set (571 in July, 588 in August) is smaller than the raw collection (800); percentages are calculated within the qualified set.
• Changes in recommendation-shaped answer share and response-type mix may make coverage comparisons more complex, independent of any single brand's performance.

Next Step

The Public Benchmark Shows Where a Brand Is Winning or Losing. A Company-Level Audit Shows Why.

Beneath the aggregate percentages lie the questions that matter for competitive position: which high-intent prompts are won, which competitor takes the recommendation when a brand loses, what attributes AI systems associate with each option, and which external sources shape those answers. The benchmark shows a category with two significant decliners and a stable leader, but it does not explain what is driving the AI systems' shortlist decisions.

A company-specific AI visibility audit maps those prompt, surface, competitor, ranking, sentiment, and evidence-source patterns into a prioritized visibility strategy. Where the benchmark tells you what changed, a company-level audit tells you why, and what to do about it.

Request an AI visibility audit